Three of the most impactful HEDIS measures are cancer screenings: breast, colorectal, and cervical. For oncology practices that also manage survivorship, the stakes go further — surveillance protocols, recurrence screening, and the downstream care gaps that cancer patients accumulate while focused on treatment. Cancer also carries some of the highest-value HCC codes in the risk adjustment model.
Glance tracks screening compliance across your attributed population, monitors survivorship care gaps, and provides the financial analytics to demonstrate the value of early detection and coordinated cancer care in VBC contracts.
Schedule a Demo See FeaturesOncology in value-based care means closing screening gaps at scale and managing survivorship with the same rigor as active treatment.
Track breast cancer screening (mammography), colorectal cancer screening (colonoscopy, FIT, Cologuard), and cervical cancer screening (Pap/HPV co-testing) rates across your attributed population. Identify patients due or overdue for each screening. Generate outreach lists by screening type, age cohort, and risk level.
Cancer survivors need surveillance imaging, lab monitoring, and ongoing screening for secondary malignancies. Glance tracks survivorship protocols by cancer type and stage, flags overdue surveillance, and ensures that the care gaps survivors accumulate during treatment (missed mammograms, deferred colonoscopies, lapsed A1c testing) get closed in survivorship.
Malignancies carry high-value HCC codes (HCC 8-12) that must be recaptured annually for active cancers and documented appropriately for remission/history. Glance surfaces patients with active cancer claims who may need recoding, patients transitioning from treatment to survivorship, and those with secondary conditions (anemia, malnutrition, pain) that carry additional HCCs.
Cancer treatment drives some of the highest per-patient costs in healthcare. Track total cost of care by cancer type, treatment phase (active vs. surveillance), and care setting. Benchmark against expected costs for each diagnosis to identify outliers and opportunities for value-based oncology contracting.
Stratify your oncology population by active treatment vs. survivorship, by cancer stage, and by comorbidity burden. Identify which survivors are also managing diabetes, heart disease, or CKD — and ensure those conditions are not being neglected during or after cancer care.